New award for amoxicillin_clavulanate tablets with sandoz, INC. Ordering period is JAN 15, 2023 to JAN 14, 2024 with four one-year options.

Active Indefinite Delivery Contract Awarded Last action

Contract number
36E79723D0001
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 95% complete
IDV ceiling
$7,402,374.05
Award type
Single award
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

Written by GovTribe AI ·

The Department of Veterans Affairs National Acquisition Center awarded a single-award indefinite-delivery contract to Sandoz Inc. on January 15, 2023, with a ceiling of $7,402,374.05 for amoxicillin-clavulanate tablets. The contract carries no set-aside.

The ordering period runs from January 15, 2023, through January 14, 2024, with four one-year options extending the potential performance through January 14, 2028. The contract implements Executive Order 14398 regarding discrimination and diversity initiatives.

Sandoz Inc. supplies pharmaceutical products through the VA's prime vendor program, delivering to VA medical centers, Department of Defense facilities, the Bureau of Prisons, and Indian Health Services locations. The contract authorizes ordering from Sandoz Inc.'s commercial catalog on an unrestricted basis. The pre-solicitation was posted August 1, 2022, with a due date of August 11, 2022.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00012 · Implementing EO 14398 DEI discrimination $0
Add Subcontract Plan P00011 · Modification P00011 is issued to incorporate sandoz INC 2026 subcontracting plan effective 01/01/2026 -12/31/2026. $0
Exercise an Option P00010 · Exercise option year 3 effective JAN 15, 2026 to JAN 14, 2027 for amoxicillin/clavulanate tablets with sandoz. $0
Add Subcontract Plan P00009 · 2025 subk small business subcontracting plan $0
Exercise an Option P00008 · Exercise option year 2 with no price changes $0
Other Administrative Action P00007 · POC administrative change $0
Supplemental Agreement for work within scope P00006 · Update to cost recovery fee (CRF) and submission of quarterly sales reports for 36E79723D0001 sandoz INC. Amoxicillin/clavulanate tablets $0
Add Subcontract Plan P00005 · Incorporate 2024 sandoz subcontracting plan for amoxicillin_clavulanate tablets with effective 01/01/2024 through 12/31/2024. $0
Exercise an Option P00004 · Exercise option year 1 effective january 15, 2024 through january 14, 2025 for amoxicillin/clavulanate tablets with sandoz, INC. Prices remain unchanged. $0
Other Administrative Action P00003 · Incorporation of drug supply chain security act (DSCSA) language $0
Add Subcontract Plan P00002 · Incorporate 2023 sandoz subcontracting plan for amoxicillin_clavulanate tablets with effective 01/01/2023 through 12/31/2023. $0
Supplemental Agreement for work within scope P00001 · NDC changes on two amoxicillin_clavulanate tablet ndcs. Old ndcs will be removed from contract. $0
Original award $0
Show all 13

Quick answers

Who was awarded contract 36E79723D0001?

36E79723D0001 was awarded to Sandoz Inc. by National Acquisition Center (Headquarters) on January 15, 2023.

How much is contract 36E79723D0001 worth?

36E79723D0001's own ceiling is $7,402,374.

Who can order from contract 36E79723D0001?

36E79723D0001 is a single award indefinite delivery contract.

Was contract 36E79723D0001 competed?

The extent of competition for 36E79723D0001 was full and open competition. The government received 2 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login